Approved Papers and Dissertations

Paper Proposals in Order of Year Approved

The following lists are in order from year 2018 in which the paper or dissertation/thesis proposals were approved. Click on the “year” to jump to the titles of approved paper proposals in that year.

Paper or dissertation/thesis proposals approval #s are in parentheses.

Paper Proposals in Order of Year Approved

 [2018] [2017] [2016] [2015] [2014]

2018

  1. (561) Crocker K, Navas-Acien A. DNA methylation and obesity phenotypes: an epigenome-wide association study among adults in the Strong Heart Study. (Approved on 2018-08-01)
  2. (560) Life expectancy associated with different ages at diagnosis of diabetes mellitus in 1.3 million adults. (Approved on 2018-06-24)
  3. (559) Powers M, Navas-Acien A. Pulmonary impairment after history of tuberculosis in American Indians in the Strong Heart Study.  (Approved on 2018-06-20)
  4. (558) Sanchez T, Uppal K. Metals and Novel Metabolism Biomarkers: Metallome Research in the Strong Heart Family Study. (Approved on 2018-06-20)
  5. (557) Riffo-Campos A,  Tellez-Plaza M. Epigenome-wide association study of cardiovascular and cancer mortality in the Strong Heart Study: An in silico analysis of common epigenetic signatures. (Approved on 2018-05-27)
  6. (556) Suchy-Dicey A. Resilience-promoting psychosocial and cultural factors in association with clinical outcomes among elderly American Indians: the Strong Heart Study. (Approved on 2018-05-27)
  7. (555) Everson T, Gribble M. Epigenetics of diabetes and diabetes-related traits in the Strong Heart Study.  (Approved on 2018-05-26)
  8. (554) Lee J. Endogenous Sex Hormones and Risk of Serious Diabetes Outcomes in Men with Diabetes: The Strong Heart Study. (Approved on 2018-05-25)
  9. (553) Lee J. Endogenous Sex Hormones and Cardio-metabolic Profiles in Men with Diabetes: The Strong Heart Study. (Approved on 2018-05-25)
  10. (552) Kummer K, Fretts A.  Dairy Consumption and Incident Diabetes Among American Indians: The Strong Heart Family Study. (Approved on 2018-05-01)
  11. (551) Eckhardt C. Associations between longitudinal lung function and the incidence of heart failure in the general population: The NHLBI Pooled Cohorts Study (including the Strong Heart Study). (Approved on 2018-05-08)
  12. (550) Domingo-Relloso A, Tellez-Plaza M. Navas-Acien A. Cadmium exposure, smoking and DNA methylation profiles in human blood DNA samples from the Strong Heart Study. (Approved on 2018-05-01)
  13. (549) Mancusi C. Myocardial Mechano-Energetic Efficiency and Insulin Resistance.  (Approved on 2018-05-01)
  14.  (548) Ritchey M. National Rates of Cardiovascular Disease Using Pooled Population Cohorts. (Approved on 2018-06-25)
  15. (547) Bozack A, Navas-Acien A. Loci-specific differential DNA methylation and urinary arsenic metabolites: An epigenome-wide association study among adults with low-to-moderate arsenic exposure. (Approved on 2018-03-31)
  16.  (545) Kauffman S, Fretts A. Interaction of Diet Quality and Blood Serum Lipid Levels in a Population at High Risk for Diabetes: The Strong Heart Family Study. (Approved on 2018-03-02)
  17. (544) Zhao J. Aspirin use, telomere length and cardiovascular disease among American Indians in The Strong Heart Family Study. (Approved on 2018-01-13)
  18. (543) Lemaitre RN. Circulating sphingolipids and incident cardiovascular disease in diabetes: the Strong Heart Study. (Approved on 2018-01-13)

2017

  1. (542) Zhao J. Telomere length and cancer mortality in American Indians: The Strong Heart Study. (Approved on 2017-12-29)
  2. (541) Tellez-Plaza M. Genetic determinants of unmodified cytosine content in human whole blood DNA: A Heritability and Quantitative Trait Locus Linkage Study in the Strong Heart Study. (Approved on 2017-11-18)
  3. (540) Spratlen MJ, Navas-Acien A.  Arsenic, one-carbon metabolism and Metabolic Syndrome in the Strong Heart Family Study. (Approved on 2017-11-18)
  4. (539) Pierce B. Sequencing-based fine-mapping of 10lq24.32/AS3MT and arsenic metabolism efficiency across three arsenic-exposed populations - Strong Heart Family Study. (Approved on 2017-11-16)
  5. (538) Balte PP. The prognostic significance of simple chronic bronchitis in the general population: the NHLBI Pooled Cohorts Study. (Approved on 2017-11-16)
  6. (537) Yi J, Navas-Acien A. Associations between metal exposure and sleep disorders in the Strong Heart Study. (Approved on 2017-11-15)
  7. (535) Zhao J. Integrated genetic and epigenetic analysis of the DNA methyltransferases family genes in relation to risk of diabetes in American Indians: the Strong Heart Study. (Approved on 2017-09-27)
  8. (534) Angelantonio ED. Comparing cardiovascular risk factors for venous and arterial thrombosis:  individual-participant data meta-analysis of 1.1 million participants in 76 prospective cohorts. (Approved on 2017-09-27)
  9. (532) Merkler AE. Unrecognized Myocardial Infarction and the Risk of Incident Ischemic Stroke in the Strong Heart Study. (Approved on 2017-08-18)
  10. (531) Losi MA. Depressed Myocardial Mechano-Energetic Efficiency is Associated with Increased Risk of Incident Heart Failure: The Strong Heart Study. (Approved on 2017-08-18)
  11. (530) Jones M. Metabolomics to Understand the Association between Arsenic Metabolism and Type 2 Diabetes: Preliminary Evidence from the Strong Heart Family Study. (Approved on 2017-09-27)
  12. (528) Fretts A, Lemaitre RN. Circulating sphingolipids and incident diabetes: the Strong Heart Study. (Approved on 2017-08-18)
  13. (527) Conner EL. The Role of Dietary Factors and Dietary Patterns on Circulating Sphingolipids: The Strong Heart Family Study. (Approved on 2017-06-10)
  14. (526) Miranda J. Association of arsenic exposure and metabolism biomarkers with diabetes-related traits. (Approved on 2017-06-10)
  15. (525) Suchy-Dicey A. Kidney function, cognitive impairment, and vascular brain injury in older American Indians. (Approved on 2017-05-10)
  16. (524) Pichler G, Navas-Acien A. The Association between Arsenic Exposure and Metabolism with Cardiac Geometry and Left Ventricular Function: Evidence from the Strong Heart Family Study. (Approved on 2017-05-09)
  17. (523) Haring B. Prognostic impact of changes in central blood pressure and left ventricular mass: Results from the Strong Heart Study. (Approved on 2017-04-08)
  18. (522) Zhao J. Telomere length and telomere attrition predict cardiovascular disease risk in American Indians: The Strong Heart Family Study. (Approved on 2017-04-08)
  19. (521) Lee J. Sex hormone levels and CVD risk in postmenopausal women with diabetes: The Strong Heart Study. (Approved on 2017-03-02)
  20. (520) Lee J. Sex hormone levels and CVD risk in men with diabetes: The Strong Heart Study. (Approved on 2017-03-02)
  21. (519) Nigra A, Navas-Acien A. Dietary sources of inorganic arsenic exposure in the Strong Heart Family Study. (Approved on 2017-02-28)
  22. (518) Almarzooq ZI. Associations of gender and diabetes mellitus with Physical Activity and Cardiovascular Mortality: The Strong Heart Study. (Approved on 2017-02-28)
  23. (517) Lewis JP. The contribution of binge drinking to hypertension, cerebrovascular disease, and stroke among older American Indians. (Approved on 2017-01-27)
  24. (516) Singh P. Physical Activity Decreases Cardiovascular Mortality via an Inflammatory Pathway:  The Strong Heart Study. (Approved on 2017-01-27)
  25. (515) Emerging Risk Factors Collaboration. Impact of re-calibrating cardiovascular risk prediction algorithms. (Approved on 2017-01-03)
  26. (514) Suchy-Dicey A. Kidney function patterns over time in the Strong Heart Study. (Approved on 2017-01-03)
  27. (511) Balakrishnan P. Cardiovascular Risk Factor Trajectories, Mortality, and Cardiovascular Disease Incidence among American Indians: The Strong Heart Study. (Approved on 2017-01-27)
  28. (507) Traore A. Impact of Stress on Fatal and Non-fatal Cardiovascular Disease among American Indians in Strong Heart Study. (Approved on 2017-05-09)
  29. (497, 536) Gribble MO, Arsenic, Blood Pressure and Hypertension in the Strong Heart Family Study. (Approved on 2015-12-08, 2017-9-28)

2016

  1. (513) Powers M, Navas-Acien A. Arsenic exposure and respiratory health in the Strong Heart Study. (Approved on 2016-11-18)
  2. (512) Oelsner EC. Harmonization of respiratory outcomes data from nine US population-based cohorts: the NHLBI Pooled Cohorts Study. (Approved on 2016-11-18)
  3. (510) Jones M, Navas-Acien A. Association between Arsenic Metabolism and Metabolic Syndrome: Evidence from the Strong Heart Family Study. (Approved on 2016-10-17)
  4. (509) Gribble MO. Arsenic Exposure, Arsenic Metabolism, and Trajectories of Diabetes-Related Traits in the Strong Heart Study. (Approved on 2016-10-17; Approved combining with #435 on July 30th, 2017)
  5. (508) Oelsner EC. Associations between Albuminuria and Incident Chronic Lower Respiratory Disease in Seven Population-Based Cohorts. (Approved on 2016-09-23)
  6. (506) Paige E. Modelling repeated measurements of blood pressure and cholesterol improves cardiovascular disease risk prediction: an individual-participant-data meta-analysis. (Approved on 2016-08-26)
  7. (505) Zamora-Kapoor A. Obesity and cognitive impairment in American Indians and Alaska Natives: Evidence from the Strong Heart Stroke Study. (Approved on 2016-07-18) (MS505 and MS533 were combined into a single manuscript (MS505). Approved by SHS P&P on 1/19/2018)
  8. (504) Zhao J. Plasma Plasminogen Activator Inhibitor-1 Antigen Predicts Risk of Incident Hypertension in American Indians: the Strong Heart Study. (Approved on 2016-05-26)
  9. (503) Zhao J. Association between Plasminogen Activator Inhibitor-1 and Biological Aging in American Indians: the Strong Heart Family Study. (Approved on 2016-04-12)
  10. (502) Nelson LA. An Urban Expansion of the Strong Heart Stroke Study: Preliminary Findings. (Approved on 2016-03-22)
  11. (501) Jensen P. Comparing Brain Imaging Findings Among American Indians in the Strong Heart Stroke Study to Whites and Blacks in the Cardiovascular Health Study and the Atherosclerosis Risk In Communities Study. (Approved on 2016-02-27)
  12. (500) Suchy-Dicey A. Metal exposure and MRI Findings of Atrophy and Vascular Brain Injury. (Approved on 2016-02-27)
  13. (499) Wang S, WITNESS: a Web InTerface to eNable secure sharEd-access to the Strong heart Study. (Approved on 2016-02-26)
  14. (498) Simone GD, Markers of preclinical CV disease and incident diabetes in the Strong Heart Study cohort. (Approved on 2016-02-26)

2015

  1. (497) Gribble MO, Arsenic, Blood Pressure and Hypertension in the Strong Heart Family Study. (Approved on 2015-12-08)
  2. (496) Zhao J. Associations between Leukocyte Telomere Length and Peripheral Artery Disease in American Indians: The Strong Heart Study. (Approved on 2015-12-08)
  3. (495) Aurora RN, Punjabi NM. Habitual Sleep Duration and Change in Sleep Duration as Predictors of All-Cause Mortality. (Approved on 2015-11-25)
  4. (494) Putcha N, Punjabi NM, Influence of Lung Function and Sleep-Disordered Breathing on All-Cause Mortality: A Community Based Study. (Approved on 2015-11-25)
  5. (493) Moon KA, Low-moderate Arsenic Exposure and Circulating Markers of Inflammation in the Strong Heart Family Study. (Approved on 2015-11-17)
  6. (492) Lemaitre RN, Circulating sphingolipids, fasting glucose and hemoglobin A1C: the Strong Heart Family Study. (Approved on 2015-11-17)
  7. (491) Chittoor G, Fine mapping and identification of serum uric acid loci in American Indians: The Strong Heart Family Study. (Approved on 2015-10-20)
  8. (490) Jones M, Navas-Acien A. Association between Arsenic Metabolism and One-Carbon Metabolism: Evidence from the Strong Heart Study. (Approved on 2015-09-16)
  9. (489) Verney ST. Cognitive Correlates of MRI-defined Vascular Brain Injury in the Strong Heart Stroke Study. (Approved on 2015-09-12)
  10. (488) Oliver-Williams C, Franceschini N. The association of Cadmium Burden and Longitudinal Blood Pressure: the Strong Heart Study. (Approved on 2015-08-24)
  11. (487) Powers M. Association of Urine Zinc with Prevalent and Incident Diabetes in the Strong Heart Study. (Approved on 2015-08-20)
  12. (486) Muller C. Age-period-cohort analysis of cardiovascular disease in American Indians: the Strong Heart Study and Strong Heart Family Study. (Approved on 2015-08-20)
  13. (485) Hardy ST. Transitioning from Ideal Blood Pressure Over the Life Course in Diverse Populations. (Approved on 2015-08-06)
  14. (484) Eilat-Adar S. The associations among coffee and caffeine intake and risk of coronary heart disease (CHD) or ischemic stroke in American Indians: The Strong Heart Study. (Approved on 2015-07-22)
  15. (483) Nigra A, Navas-Acien A. Associations between urinary tungsten and incident cardiovascular disease in the Strong Heart Study. (Approved on 2015-07-22)
  16. (482) Lemaitre RN. Acute Myocardial Infarction in American Indians:  STEMI vs. NSTEMI, Analysis of Strong Heart Study vs. Framingham Heart Study. (Approved on 2015-06-08)
  17. (481) Engeda JC. Net Transitions between Ideal, Intermediate, and Poor Levels of Total Cholesterol and Low Density Lipoproteins. (Approved on 2015-06-08)
  18. (480) Haring B. Processed and unprocessed meat intake, cardiac phenotype and vascular biomarkers:  Results from the Strong Heart Study. (Approved on 2015-05-14)
  19. (479) Shibata DK. Vascular risk factors and findings on brain MRI of elderly American Indians in the Strong Heart Stroke Study (paper 2). (Approved on 2015-05-14)
  20. (478) Grau-Perez M, Tellez-Plaza M. Association of arsenic and cadmium exposure with Leukocyte Telomere Length among American Indians in the Strong Heart Study. (Approved on 2015-04-09)
  21. (477) North K. Genetic Determinants of Anthropometric Traits in the Strong Heart Family Study. (Approved on 2015-04-09)
  22. (476) Angelantonio ED, Danesh J. N-terminal pro-B-type natriuretic peptide and prediction of cardiovascular disease. (Approved on 2015-04-09)
  23. (475) Hagerty T. Acute Myocardial Infarction in American Indians:  STEMI vs. NSTEMI, Analysis of Strong Heart Study vs. Framingham Heart Study. (Approved on 2015-04-01)
  24. (474) Moon KA. Low-moderate Arsenic Exposure and Electrocardiographic Abnormalities in the Strong Heart Study. (Approved on 2015-03-12)
  25. (473) Suchy-Dicey AM. Leukocyte telomere length and findings on cranial MRI: the Strong Heart Stroke Study. (Approved on 2015-03-12)
  26. (472) Shibata DK. Vascular risk factors and findings on brain MRI of elderly American Indians in the Strong Heart Stroke Study (paper 1). (Approved on 2015-05-14)
  27. (471) Grau-Perez M, Tellez-Plaza M. Genetic Determinants of Cadmium Exposure among American Indians in the Strong Heart Family Study. (Approved on 2015-02-10)
  28. (470) Danesh J, Angelantonio ED. Global and region-specific relationships of body-mass index and mortality: Collaborative analysis of 8.8 Million people in 233 prospective studies. (Approved on 2015-01-23)
  29. (469) Zhao J. Life’s simple 7 and telomere length in American Indians: The Strong Heart Family Study. (Approved on 2015-01-14)
  30. (468) Zhao J. Change-point proportional hazards model for clustered event data: an application to the Strong Heart Study. (Approved on 2015-01-15)
  31. (467) Zhao J. Telomere attrition and its impact on cardiac structural and functional changes in American Indians. (Approved on 2015-01-14)
  32. (466) Cholerton B, Calhoun D. Midlife insulin resistance and later cognitive function in older American Indians: The Strong Heart Stroke Study. (Approved on 2015-01-14)

2014

  1. (422) Tsai CW.  The association of five candidate genes and arsenic methylation in American Indians. (Approved on 2013-01-31)
  2. (423) Nicklett EJ.  Why does place matter? Examining differences in diabetes-related outcomes among Native American with type 2 diabetes by geographic density and distance to service. (Approved on 2013-01-31)
  3. (424) Gribble MO.  SLCO1B1 Variants and Urine Arsenic Metabolites in the Strong Heart Family Study. (Approved on 2013-01-31)
  4. (416) Zhao J. Metabolic profiles of biological aging in American Indians: The Strong Heart Family Study. (Approved on 2014-02-08)
  5. (417) Zhao J. Metabolic profiles and predictors for risk of type 2 diabetes in American Indians: The Strong Heart Family Study. (Approved on 2014-02-08)
  6. (425) Melton PE. Pharmacogenomics of glucuronidation in American Indians: The Strong Heart Family Study. (Approved on 2014-02-08)
  7. (426) Gribble MO. Arsenic Interactions with Genetic Determinants of Glycemia: Linkage and Association Analysis in the Strong Heart Family Study. (Approved on 2014-02-08)
  8. (427) Tsai CW. The association of PCSK9 polymorphism and metabolic traits in American Indians. (Approved on 2014-03-01)
  9. (428) Kuo CC. Arsenic metabolism and chronic kidney disease in the Strong Heart Study. (Approved on 2014-03-01)
  10. (429) Kuo CC. Arsenic exposure and metabolism and all-cause mortality in Strong Heart Study. (Approved on 2014-03-01)
  11. (430) Kuo CC. Arsenic Exposure and Incident Diabetes in the Strong Heart Study. (Approved on 2014-03-01)
  12. (431) Fretts AM. Meat Intake and Telomere Length: The Strong Heart Family Study. (Approved on 2014-03-01)
  13. (432) Fretts AM. Physical Activity and Telomere Length: The Strong Heart Family Study. (Approved on 2014-03-01)
  14. (436) Mateen FJ, Navas-Acien A. Urine arsenic exposure and Carotid Artery Vascular Disease: Prospective evidence from the Strong Heart Study. (Approved on 2014-03-29)
  15. (437) Deen JF. Sex Differences in QRS Duration and Associated Cardiovascular Events:  The Strong Heart Study. (Approved on 2014-05-08)
  16. (438) Marco MD. Sex difference in the cardiovascular risk associated with left ventricular hypertrophy:  The Strong Heart Study. (Approved on 2014-06-05)
  17. (439) Bang CN. Validation of a new 4-group Classification of Left Ventricular Hypertrophy Based on left Ventricular Geometry in a Population-Based Sample:  The Strong Heart Study. (Approved on 2014-06-05)
  18. (435) Kuo CC, Navas-Acien A. Arsenic Exposure and Incident Diabetes in the Strong Heart Family Study. (Approved on 2014-07-02; Approved combining with #509 on July 30th, 2017)
  19. (440) Carroll C. Latent Neuropsychological Effects of Chronic Low-Level Arsenic Exposure in American Indian Elders. (Approved on 2014-06-26)
  20. (441) Gribble MO. Genome-wide Linkage Analysis of Urine Arsenic Metabolites in the Strong Heart Family Study. (Approved on 2014-06-28)
  21. (442) Tsai CW. The association between obesity and kidney diseases in American Indians. (Approved on 2014-07-01)
  22. (443) Simone G. Hemodynamic correlates of aortic root dimensions in an adult population: the Strong Heart Study. (Approved on 2014-07-02)
  23. (444) Shara NM. Evaluation of the Pooled Cohort Equations for Cardiovascular Risk Prediction in a Population with high Prevalence of Obesity and Diabetes: The Strong Heart Study. (Approved on 2014-07-02)
  24. (445) Balakrishnan P, Navas-Acien A. Genetic Determinants of Incident Diabetes and Diabetes-Related Traits among American Indians in the Strong Heart Family Study. (Approved on 2014-07-15)
  25. (446) Gribble MO. Psychosocial Factors and Susceptibility to Arsenic for All-Cause Mortality in the Strong Heart Study. (Approved on 2014-07-16)
  26. (447) Newman JD. Inorganic arsenic exposure and incident peripheral arterial disease: the Strong Heart Study. (Approved on 2014-07-16)
  27. (448) Ton TGN. Brain imaging findings in Native Americans: The Strong Heart Stroke Study. (Approved on 2014-07-16)
  28. (449) Franceschini N. Association of coding variants in the CUBN gene with albuminuria in American Indians: The Strong Heart Family Study. (Approved on 2014-08-12)
  29. (450) Yeh F. The prevalence of Cardiovascular Disease Risk Factors in American Indian Communities: The Strong Heart Family Study. (Approved on 2014-08-13)
  30. (451) Muller C. Comparing stroke incidence and survival in American Indians, Blacks, and Whites: the Strong Heart Study, Atherosclerosis Risk in Communities Study, and the Cardiovascular Health Study. (Approved on 2014-08-13)
  31. (452) Wang W. Relationship of HbA1c and FPG and their performances in identifying new DM:   Strong Heart Study. (Approved on 2014-08-13)
  32. (454) Kaptoge S, Danesh J. Emerging Risk Factors Collaboration (ERFC): Diabetes duration and mortality. (Approved on 2014-08-18)
  33. (412) Shibata DK. Stroke and TIA Correlates of Brain MRI Abnormalities in the Strong Heart Stroke Study. (Approved on 2014-09-11)
  34. (455) Franceschini N, Cole SA. Genetic determinants of hypertension and kidney traits in American Indians: The Strong Heart Family Study. (Approved on 2014-09-11)
  35. (456) Balakrishnan P, Navas-Acien A. Genetic Determinants of Arsenic Exposure and Arsenic Metabolites among American Indians in the Strong Heart Family Study. (Approved on 2014-09-11)
  36. (457) Cole SA. Genome-wide association and trans-ethnic meta-analysis for advanced diabetic kidney disease: Family Investigation of Nephropathy and Diabetes (FIND). (Approved on 2014-09-24)
  37. (459) Traurig M, Baier LJ, Bogardus C. Interaction between SLC16A11 genotype and BMI conveys a nominal risk for type 2 diabetes in 13267 American Indians. (Approved on 2014-11-14)
  38. (460) Haring B. Left-ventricular Mass, MRI indices and Cognitive Functioning: Results from the Strong Heart Study. (Approved on 2014-11-14)
  39. (461) Zhao J. Novel metabolic markers for carotid plaque onset and progression in American Indians. (Approved on 2014-11-14)
  40. (462) Fretts AM. Artificial Sweeteners and Glucose Intolerance: the Strong Heart Family Study. (Approved on 2014-11-14)
  41. (463) Zhao J. Metabolic profiles of obesity in American Indians. (Approved on 2014-11-20)
  42. (464) Olmedo-Palma P,  Navas-Acien A. Dietary Determinants of Cadmium Exposure: Evidence from the Strong Heart Family Study. (Approved on 2014-12-10)
  43. (465) Dele-Michael A. Vascular structure and function as a predictor of left ventricular remodeling and hypertrophy:  The Strong Heart Study. (Approved on 2014-12-10)

Dissertation or Thesis Proposals Approved

  1. (T27) Powers M, Navas-Acien A, Low-moderate Arsenic Exposure and Respiratory Health in American Indian Communities. (Approved on 2017-01-03)
  2. (T26) Conner EL, Lemaitre RN, The Role of Diet Quality and Dietary Factors on Circulating Sphingolipids: The Strong Heart Family Study. (Approved on 2016-11-18)
  3. (T25) Mattison C, Gribble M. Arsenic, Blood Pressure and Hypertension in the Strong Heart Family Study. (Approved on 2016-05-27)
  4. (T24) Kummer K, Fretts AM. Dairy consumption and incident type 2 diabetes among American Indians: the Strong Heart Family Study. (Approved on 2016-02-26)
  5. (T23) Moon K, Navas-Acien A. Subclinical and Clinical Cardiovascular Effects of Low-Moderate Arsenic: Evidence for Risk Assessment. (Approved on 2016-04-12)
  6. (T22) Kauffman SAE, Fretts AM. The Relationship of Diet Quality and Blood Serum Lipid Levels in a Population at High Risk for Diabetes: the Strong Heart Family Study. (Approved on 2015-08-24)
  7. (T21) Traore A, Eichner J. Impact of Stress on Fatal and Non-fatal Cardiovascular Disease among American Indians. (Approved on 2015-05-14)
  8. (T20) Kuo CC, Navas-Acien A. Arsenic exposure, metabolism and diabetes care in the Strong Heart Study. (Approved on 2014-06-30)
  9. (T19) Zheng L. Arsenic and Incident Chronic Kidney Disease in the Strong Heart Study. (Approved on 2014-02-08)